Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19584271 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting IST Neoadjuvant Abraxane in Newly Diagnosed Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Nab-Paclitaxel

Indicates status has not been verified in more than two years